Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1993 Jul;53(1):150–167.

HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls.

I Kockum 1, R Wassmuth 1, E Holmberg 1, B Michelsen 1, A Lernmark 1
PMCID: PMC1682248  PMID: 8317480

Abstract

The association between HLA-DR and -DQ and insulin-dependent diabetes mellitus (IDDM) in a defined high-incidence area was analyzed in a total of 58 population-based patients, representing 77% of IDDM patients with age at onset below 16 years, and in 92 unrelated parents in control families without IDDM. HLA haplotypes were confirmed by analyzing first-degree relatives in both groups. Seven different methods were used to analyze risk: (1) odds ratio, (2) absolute risk, (3) haplotype relative risk, (4) transcomplementation relative risk, (5) relative predisposing effects, (6) stratification analysis, and (7) test of predisposing allele on haplotype. DQB1*0302 indicated somewhat higher risk than did DR4, while DR3 had a higher risk than DQB1*0201; however, the 95% confidence intervals of the risk estimates overlapped. The positive association between IDDM and the DQB1*0201-DQA1*0501-DR3 haplotype seems to be due to DR3 or to an unknown linked gene. More important, DQA1*0301 was present among 93% of the patients, and this allele in various transcomplementation combinations with DQB1 alleles showed closer association to IDDM than did any other alleles. The strong negative association of the DQB1*0602 allele also in the presence of either DR4 or DQB1*0302 or both suggests that, in a high-risk population for IDDM, HLA-DQ primarily confers protection, perhaps by induction of tolerance. Consistent with known functions, HLA-DR may primarily confer susceptibility, perhaps by induction of autoreactive T lymphocytes.

Full text

PDF
150

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altmann D. M., Sansom D., Marsh S. G. What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today. 1991 Aug;12(8):267–270. doi: 10.1016/0167-5699(91)90124-C. [DOI] [PubMed] [Google Scholar]
  2. Aparicio J. M., Wakisaka A., Takada A., Matsuura N., Aizawa M. HLA-DQ system and insulin-dependent diabetes mellitus in Japanese: does it contribute to the development of IDDM as it does in Caucasians? Immunogenetics. 1988;28(4):240–246. doi: 10.1007/BF00345500. [DOI] [PubMed] [Google Scholar]
  3. Awata T., Kuzuya T., Matsuda A., Iwamoto Y., Kanazawa Y., Okuyama M., Juji T. High frequency of aspartic acid at position 57 of HLA-DQ beta-chain in Japanese IDDM patients and nondiabetic subjects. Diabetes. 1990 Feb;39(2):266–269. doi: 10.2337/diab.39.2.266. [DOI] [PubMed] [Google Scholar]
  4. Badenhoop K., Schwarz G., Bingley P., Lewis V., Drummond V., Gale E. A., Bottazzo G. F. Restriction fragment length polymorphism analysis of HLA haplotypes in families with type I diabetes mellitus. Tissue Antigens. 1990 Jan;35(1):32–39. doi: 10.1111/j.1399-0039.1990.tb01752.x. [DOI] [PubMed] [Google Scholar]
  5. Baisch J. M., Weeks T., Giles R., Hoover M., Stastny P., Capra J. D. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med. 1990 Jun 28;322(26):1836–1841. doi: 10.1056/NEJM199006283222602. [DOI] [PubMed] [Google Scholar]
  6. Barbosa J., Chern M. M., Anderson V. E., Noreen H., Johnson S., Reinsmoen N., McCarty R., King R., Greenberg L. Linkage analysis between the major histocompatibility system and insulin-dependent diabetes in families with patients in two consecutive generations. J Clin Invest. 1980 Mar;65(3):592–601. doi: 10.1172/JCI109704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bhatia E., Mehra N. K., Malaviya A. N., Ahuja M. M. HLA and autoimmunity in North Indian type I (insulin-dependent) diabetic multiplex families. Horm Metab Res. 1986 May;18(5):331–334. doi: 10.1055/s-2007-1012308. [DOI] [PubMed] [Google Scholar]
  8. Bloom B. R., Salgame P., Diamond B. Revisiting and revising suppressor T cells. Immunol Today. 1992 Apr;13(4):131–136. doi: 10.1016/0167-5699(92)90110-S. [DOI] [PubMed] [Google Scholar]
  9. Bodmer J. G., Marsh S. G., Parham P., Erlich H. A., Albert E., Bodmer W. F., Dupont B., Mach B., Mayr W. R., Sasazuki T. Nomenclature for factors of the HLA system, 1989. Hum Immunol. 1990 Jul;28(3):326–342. doi: 10.1016/0198-8859(90)90060-3. [DOI] [PubMed] [Google Scholar]
  10. Bruserud O., Paulsen G., Markussen G., Lundin K., Thoresen A. B., Thorsby E. Genomic HLA-DQ beta polymorphism associated with insulin-dependent diabetes mellitus. Analysis of possible functional significance. Scand J Immunol. 1987 Mar;25(3):235–243. doi: 10.1111/j.1365-3083.1987.tb01069.x. [DOI] [PubMed] [Google Scholar]
  11. Böhme J., Carlsson B., Wallin J., Möller E., Persson B., Peterson P. A., Rask L. Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol. 1986 Aug 1;137(3):941–947. [PubMed] [Google Scholar]
  12. Chang H. C., Moriuchi T., Silver J. The heavy chain of human B-cell alloantigen HLA-DS has a variable N-terminal region and a constant immunoglobulin-like region. 1983 Oct 27-Nov 2Nature. 305(5937):813–815. doi: 10.1038/305813a0. [DOI] [PubMed] [Google Scholar]
  13. Cohen-Haguenauer O., Robbins E., Massart C., Busson M., Deschamps I., Hors J., Lalouel J. M., Dausset J., Cohen D. A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1985 May;82(10):3335–3339. doi: 10.1073/pnas.82.10.3335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cudworth A. G., Woodrow J. C. HL-A system and diabetes mellitus. Diabetes. 1975 Apr;24(4):345–349. doi: 10.2337/diab.24.4.345. [DOI] [PubMed] [Google Scholar]
  15. Dunston G. M., Henry L. W., Christian J., Ofosu M. D., Callender C. O. HLA-DR3, DQ heterogeneity in American blacks is associated with susceptibility and resistance to insulin dependent diabetes mellitus. Transplant Proc. 1989 Feb;21(1 Pt 1):653–655. [PubMed] [Google Scholar]
  16. Easteal S., Viswanathan M., Serjeantson S. W. HLA-DP, -DQ and -DR RFLP types in south Indian insulin-dependent diabetes mellitus patients. Tissue Antigens. 1990 Feb;35(2):71–74. doi: 10.1111/j.1399-0039.1990.tb01759.x. [DOI] [PubMed] [Google Scholar]
  17. Falk C. T., Rubinstein P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet. 1987 Jul;51(Pt 3):227–233. doi: 10.1111/j.1469-1809.1987.tb00875.x. [DOI] [PubMed] [Google Scholar]
  18. Fletcher J., Mijovic C., Odugbesan O., Jenkins D., Bradwell A. R., Barnett A. H. Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to type 1 (insulin-dependent) diabetes. Diabetologia. 1988 Dec;31(12):864–870. doi: 10.1007/BF00265368. [DOI] [PubMed] [Google Scholar]
  19. Fletcher J., Odugbesan O., Mijovic C., Mackay E., Bradwell A. R., Barnett A. H. Class II HLA DNA polymorphisms in type 1 (insulin-dependent) diabetic patients of north Indian origin. Diabetologia. 1988 Jun;31(6):343–350. doi: 10.1007/BF02341501. [DOI] [PubMed] [Google Scholar]
  20. HALDANE J. B. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet. 1956 May;20(4):309–311. doi: 10.1111/j.1469-1809.1955.tb01285.x. [DOI] [PubMed] [Google Scholar]
  21. Hawkins B. R., Lam K. S., Ma J. T., Low L. C., Cheung P. T., Serjeantson S. W., Yeung R. T. Strong association of HLA-DR3/DRw9 heterozygosity with early-onset insulin-dependent diabetes mellitus in Chinese. Diabetes. 1987 Nov;36(11):1297–1300. doi: 10.2337/diab.36.11.1297. [DOI] [PubMed] [Google Scholar]
  22. Henson V., Maclaren N., Riley W., Wakeland E. K. Polymorphisms of DQ beta genes in HLA-DR4 haplotypes from healthy and diabetic individuals. Immunogenetics. 1987;25(3):152–160. doi: 10.1007/BF00344028. [DOI] [PubMed] [Google Scholar]
  23. Hirayama K., Matsushita S., Kikuchi I., Iuchi M., Ohta N., Sasazuki T. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature. 1987 Jun 4;327(6121):426–430. doi: 10.1038/327426a0. [DOI] [PubMed] [Google Scholar]
  24. Hitman G. A., Mohan V. The genetic susceptibility to IDDM in British and south Indian subjects. Biomed Biochim Acta. 1988;47(4-5):329–336. [PubMed] [Google Scholar]
  25. Hurley C. K., Gregersen P. K., Gorski J., Steiner N., Robbins F. M., Hartzman R., Johnson A. H., Silver J. The DR3(w18),DQw4 haplotype differs from DR3(w17),DQw2 haplotypes at multiple class II loci. Hum Immunol. 1989 May;25(1):37–50. doi: 10.1016/0198-8859(89)90068-2. [DOI] [PubMed] [Google Scholar]
  26. Hägglöf B., Holmgren G., Holmlund G., Lindblom B., Olaisen B., Teisberg P. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden. Hum Hered. 1986;36(4):201–212. doi: 10.1159/000153627. [DOI] [PubMed] [Google Scholar]
  27. Hägglöf B., Holmgren G., Wall S. Incidence of insulin-dependent diabetes mellitus among children in a North-Swedish population 1938-1977. Hum Hered. 1982;32(6):408–417. doi: 10.1159/000153330. [DOI] [PubMed] [Google Scholar]
  28. Jenkins D., Mijovic C., Fletcher J., Jacobs K. H., Bradwell A. R., Barnett A. H. Identification of susceptibility loci for type 1 (insulin-dependent) diabetes by trans-racial gene mapping. Diabetologia. 1990 Jul;33(7):387–395. doi: 10.1007/BF00404086. [DOI] [PubMed] [Google Scholar]
  29. Jenkins D., Mijovic C., Jacobs K. H., Penny M. A., Fletcher J., Barnett A. H. Allele-specific gene probing supports the DQ molecule as a determinant of inherited susceptibility to type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1991 Feb;34(2):109–113. doi: 10.1007/BF00500381. [DOI] [PubMed] [Google Scholar]
  30. Ju L. Y., Sun Y. P., Semana G., Gu X. F., Krishnamoorty R., Fauchet R., Charron D. Aspartic acid at position 57 of the HLA-DQ beta chain in insulin-dependent diabetes mellitus: an association with one DRw9-DQw9 subtype in the Chinese population. Tissue Antigens. 1991 May;37(5):218–223. doi: 10.1111/j.1399-0039.1991.tb01875.x. [DOI] [PubMed] [Google Scholar]
  31. Khalil I., d'Auriol L., Gobet M., Morin L., Lepage V., Deschamps I., Park M. S., Degos L., Galibert F., Hors J. A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest. 1990 Apr;85(4):1315–1319. doi: 10.1172/JCI114569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Long E. O., Wake C. T., Gorski J., Mach B. Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes. EMBO J. 1983;2(3):389–394. doi: 10.1002/j.1460-2075.1983.tb01435.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Maeda H., Takeuchi F., Juji T., Akanuma Y., Kasuga M., Lee Y. S., Kosaka K., Tsai S. H. HLA-DRw3 in juvenile onset diabetes mellitus in Chinese. Tissue Antigens. 1980 Feb;15(2):173–176. doi: 10.1111/j.1399-0039.1980.tb00901.x. [DOI] [PubMed] [Google Scholar]
  34. Michelsen B., Lernmark A. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ. J Clin Invest. 1987 Apr;79(4):1144–1152. doi: 10.1172/JCI112931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976 Feb;103(2):226–235. doi: 10.1093/oxfordjournals.aje.a112220. [DOI] [PubMed] [Google Scholar]
  36. Mijovic C. H., Jenkins D., Jacobs K. H., Penny M. A., Fletcher J. A., Barnett A. H. HLA-DQA1 and -DQB1 alleles associated with genetic susceptibility to IDDM in a black population. Diabetes. 1991 Jun;40(6):748–753. doi: 10.2337/diab.40.6.748. [DOI] [PubMed] [Google Scholar]
  37. Monos D. S., Spielman R. S., Gogolin K. J., Radka S. F., Baker L., Zmijewski C. M., Kamoun M. HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQ beta restriction fragments and DQ beta chain variation. Immunogenetics. 1987;26(4-5):299–303. doi: 10.1007/BF00346526. [DOI] [PubMed] [Google Scholar]
  38. Nepom B. S., Palmer J., Kim S. J., Hansen J. A., Holbeck S. L., Nepom G. T. Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med. 1986 Jul 1;164(1):345–350. doi: 10.1084/jem.164.1.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Nepom G. T. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes. 1990 Oct;39(10):1153–1157. doi: 10.2337/diab.39.10.1153. [DOI] [PubMed] [Google Scholar]
  40. Nerup J., Platz P., Andersen O. O., Christy M., Lyngsoe J., Poulsen J. E., Ryder L. P., Nielsen L. S., Thomsen M., Svejgaard A. HL-A antigens and diabetes mellitus. Lancet. 1974 Oct 12;2(7885):864–866. doi: 10.1016/s0140-6736(74)91201-x. [DOI] [PubMed] [Google Scholar]
  41. Olerup O., Smith C. I., Björkander J., Hammarström L. Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10653–10657. doi: 10.1073/pnas.89.22.10653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Owerbach D., Gunn S., Gabbay K. H. Primary association of HLA-DQw8 with type I diabetes in DR4 patients. Diabetes. 1989 Jul;38(7):942–945. doi: 10.2337/diab.38.7.942. [DOI] [PubMed] [Google Scholar]
  43. Payami H., Joe S., Farid N. R., Stenszky V., Chan S. H., Yeo P. P., Cheah J. S., Thomson G. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet. 1989 Oct;45(4):541–546. [PMC free article] [PubMed] [Google Scholar]
  44. Platz P., Jakobsen B. K., Morling N., Ryder L. P., Svejgaard A., Thomsen M., Christy M., Kromann H., Benn J., Nerup J. HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia. 1981 Aug;21(2):108–115. doi: 10.1007/BF00251276. [DOI] [PubMed] [Google Scholar]
  45. Reijonen H., Ilonen J., Knip M., Michelsen B., Akerblom H. K. HLA-DQ beta-chain restriction fragment length polymorphism as a risk marker in type 1 (insulin-dependent) diabetes mellitus: a Finnish family study. Diabetologia. 1990 Jun;33(6):357–362. doi: 10.1007/BF00404640. [DOI] [PubMed] [Google Scholar]
  46. Rubinstein P., Walker M., Mollen N., Carpenter C., Beckerman S., Suciu-Foca N., McEvoy R., Ginsberg-Fellner F. No excess of DR*3/4 in Ashkenazi Jewish or Hispanic IDDM patients. Diabetes. 1990 Sep;39(9):1138–1143. doi: 10.2337/diab.39.9.1138. [DOI] [PubMed] [Google Scholar]
  47. Rønningen K. S., Gjertsen H. A., Iwe T., Spurkland A., Hansen T., Thorsby E. Particular HLA-DQ alpha beta heterodimer associated with IDDM susceptibility in both DR4-DQw4 Japanese and DR4-DQw8/DRw8-DQw4 whites. Diabetes. 1991 Jun;40(6):759–763. doi: 10.2337/diab.40.6.759. [DOI] [PubMed] [Google Scholar]
  48. Singal D. P., Blajchman M. A. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes. 1973 Jun;22(6):429–432. doi: 10.2337/diab.22.6.429. [DOI] [PubMed] [Google Scholar]
  49. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  50. Sterkers G., Zeliszewski D., Chaussée A. M., Deschamps I., Font M. P., Freidel C., Hors J., Betuel H., Dausset J., Levy J. P. HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6473–6477. doi: 10.1073/pnas.85.17.6473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Svejgaard A., Ryder L. P. HLA and insulin-dependent diabetes: an overview. Genet Epidemiol. 1989;6(1):1–14. doi: 10.1002/gepi.1370060104. [DOI] [PubMed] [Google Scholar]
  52. Thomson G. HLA DR antigens and susceptibility to insulin-dependent diabetes mellitus. Am J Hum Genet. 1984 Nov;36(6):1309–1317. [PMC free article] [PubMed] [Google Scholar]
  53. Thomson G., Robinson W. P., Kuhner M. K., Joe S., MacDonald M. J., Gottschall J. L., Barbosa J., Rich S. S., Bertrams J., Baur M. P. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet. 1988 Dec;43(6):799–816. [PMC free article] [PubMed] [Google Scholar]
  54. Todd J. A., Bell J. I., McDevitt H. O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 1987 Oct 15;329(6140):599–604. doi: 10.1038/329599a0. [DOI] [PubMed] [Google Scholar]
  55. Todd J. A., Fukui Y., Kitagawa T., Sasazuki T. The A3 allele of the HLA-DQA1 locus is associated with susceptibility to type 1 diabetes in Japanese. Proc Natl Acad Sci U S A. 1990 Feb;87(3):1094–1098. doi: 10.1073/pnas.87.3.1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Todd J. A., Mijovic C., Fletcher J., Jenkins D., Bradwell A. R., Barnett A. H. Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature. 1989 Apr 13;338(6216):587–589. doi: 10.1038/338587a0. [DOI] [PubMed] [Google Scholar]
  57. Vadheim C. M., Zeidler A., Rotter J. I., Langbaum M., Shulman I. A., Spencer M. R., Costin G., Riley W. J., Maclaren N. K. Different HLA haplotypes in Mexican Americans with IDDM. Diabetes Care. 1989 Jul-Aug;12(7):497–500. doi: 10.2337/diacare.12.7.497. [DOI] [PubMed] [Google Scholar]
  58. Vallet-Colom I., Lévy-Marchal C., Zarrouk D., Tichet J., Krishnamoorthy R., Czernichow P., Elion J. HLA-DQB 1 codon 57 and genetic susceptibility to type 1 (insulin-dependent) diabetes mellitus in French children. Diabetologia. 1990 Mar;33(3):174–176. doi: 10.1007/BF00404046. [DOI] [PubMed] [Google Scholar]
  59. WOOLF B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955 Jun;19(4):251–253. doi: 10.1111/j.1469-1809.1955.tb01348.x. [DOI] [PubMed] [Google Scholar]
  60. Wassmuth R., Lernmark A. The genetics of susceptibility to diabetes. Clin Immunol Immunopathol. 1989 Dec;53(3):358–399. doi: 10.1016/0090-1229(89)90002-0. [DOI] [PubMed] [Google Scholar]
  61. Yamagata K., Hanafusa T., Nakajima H., Sada M., Amemiya H., Noguchi T., Tanaka T., Kono N., Tarui S. HLA-DQA1*1 contributes to resistance and A1*3 confers susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia. 1991 Feb;34(2):133–136. doi: 10.1007/BF00500386. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES